forked from NBCLab/NBCLab.github.io
-
Notifications
You must be signed in to change notification settings - Fork 4
Commit
This commit does not belong to any branch on this repository, and may belong to a fork outside of the repository.
- Loading branch information
Showing
2 changed files
with
40 additions
and
0 deletions.
There are no files selected for viewing
Loading
Sorry, something went wrong. Reload?
Sorry, we cannot display this file.
Sorry, this file is invalid so it cannot be displayed.
40 changes: 40 additions & 0 deletions
40
papers/_posts/2024-08-09-hohmann-heterologous-expression-of.md
This file contains bidirectional Unicode text that may be interpreted or compiled differently than what appears below. To review, open the file in an editor that reveals hidden Unicode characters.
Learn more about bidirectional Unicode characters
Original file line number | Diff line number | Diff line change |
---|---|---|
@@ -0,0 +1,40 @@ | ||
--- | ||
layout: paper | ||
title: "Heterologous Expression of a Cryptic BGC from Bilophila sp. Provides Access to a Novel Family of Antibacterial Thiazoles" | ||
nickname: {nickname} | ||
authors: "Hohmann M, Iliasov D, Larralde M, Johannes W, Janßen KP, Zeller G, Mascher T, Gulder T" | ||
year: "2024" | ||
journal: "ChemRxiv" | ||
volume: | ||
issue: | ||
pages: | ||
is_published: false | ||
image: /assets/images/papers/chemrxiv.png | ||
projects: secondary-metabolism | ||
tags: ["preprint"] | ||
|
||
# Text | ||
fulltext: | ||
pdf: | ||
pdflink: | ||
pmcid: | ||
preprint: https://doi.org/10.26434/chemrxiv-2024-qlv3n | ||
supplement: | ||
|
||
# Links | ||
doi: "10.26434/chemrxiv-2024-qlv3n" | ||
pmid: | ||
|
||
# Data and code | ||
github: | ||
neurovault: | ||
openneuro: | ||
figshare: | ||
figshare_names: | ||
osf: | ||
--- | ||
{{% include JB/setup %}} | ||
|
||
# Abstract | ||
|
||
Human health is greatly influenced by the gut microbiota and microbiota imbalance can lead to the development of diseases. It is widely acknowledged that the interaction of bacteria within competitive ecosystems is influenced by their specialized metabolites, which act, e.g., as antibacterials or siderophores. However, our understanding of the occurrence and impact of such natural products in the human gut microbiome remains very limited. As arylthiazole siderophores are an emerging family of growth-promoting molecules in pathogenic bacteria, we analyzed a metagenomic dataset from the human microbiome and thereby identified the bil-BGC, which originates from an uncultured Bilophila strain. Through gene synthesis and BGC assembly, heterologous expression and mutasynthetic experiments, we discovered bilothiazoles A-F, new arylthiazole natural products. While established activities of related molecules indicate their involvement in metal-binding and -uptake, which could promote the growth of pathogenic strains, we also found antibiotic activity for some bilothiazoles. This is supported by biosensor-experiments, where bilothiazoles C and E show PrecA-suppressing activity, while bilothiazole F induces PblaZ, a biosensor characteristic for -lactam antibiotics. These findings serve as a starting point for investigating the role of bilothiazoles in the pathogenicity of Bilophila species in the gut. |